Navigation Links
Sidec Announces the First Protein Tomography(TM) Award at Sidec's Executive Forum at PEGS

BOSTON, Massachusetts, May 1 /PRNewswire/ -- Sidec announces the first Protein Tomography(TM) Award at Sidec's Executive Forum at PEGS. This Award is set up to enable research groups in the biopharmaceutical industry, who have not yet collaborated with Sidec on a Protein Tomography(TM) study, to get acquainted with Sidec's groundbreaking technology successfully used in cancer drug research.

(Logo: )

Sidec announced today the first Protein Tomography(TM) Award. The winning project will obtain a Protein Tomography(TM) collaboration financed by Sidec. This announcement was made at Sidec's Executive Forum during the fourth Annual PEGS meeting organized by CHI.

The use of Protein Tomography(TM) to answer questions related to therapeutic antibody development was presented at Sidec's Executive Forum. Berkley Lynch, previously Principal Investigator at UCB, spoke about the use of Protein Tomography(TM) to Image the Synaptic Vesicle of protein 2A in situ and Jose R. Casas-Finet, Director, R&D and Medical Biochemistry, MedImmune showed how antibody conformations and interactions can be studied by Protein Tomography(TM). At the Forum, Wim, K. Bleeker, Director Translational Research & Pharmacology at Genmab presented the modes of action of HuMax-EGFr (zalutumumab) published in PNAS April 22nd and how this was determined together with Sidec using Protein Tomography(TM).

Finally, Kathleen Madden Williams, PhD, JD Edwards Agnell Palmer & Dodge LLP discussed the ever-narrowing tunnel that present day patent protection on antibodies has entered and whether there is a gold standard by which antibodies are distinguishable from one another thereby to enable more meaningful patent protection.

"During PEGS it became obvious that studying molecular mechanisms is indeed a crucial step in antibody development. Even for some of the best studied anti cancer drug targets, such as CD20, a fundamental understanding of the drug mechanisms is still lacking. Hence, Sidec's Protein Tomography(TM) Award fills an important role in encouraging research groups in the biopharmaceutical industry to try a new avenue, such as Protein Tomography(TM), to increase their chances of success" says Hans Johansson CEO at Sidec AB.

About Sidec:

Sidec studies molecular interactions in situ and in vitro using its proprietary technology Protein Tomography(TM). Sidec AB offers collaborative research projects to the biopharmaceutical industry that reveal unique information to prioritize the most promising therapeutic antibody and to locate the antibody binding epitope.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Amazing minaturized SIDECAR drives Webb telescopes signal
2. DermAvance Pharmaceuticals Announces Investment by Ben Franklin Technology Partners of Southeastern Pennsylvania
3. Baxa Announces Colorado BioScience Association Sponsorship
4. Poniard Pharmaceuticals Announces Upcoming Conference Participation
5. Anesiva Announces First Quarter 2008 Financial Results Conference Call and Webcast
6. Anesiva Announces Expansion of Zingo Agreement in Europe
7. Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results
8. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
9. BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center
10. Sigma-Aldrich Announces the Integration of Riedel-De Haen Into Core Product Brands
11. Oncolytics Biotech Inc. Announces 2008 First Quarter Results
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... Amgen, will join the faculty of the University of North Carolina Kenan-Flagler ... of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s ...
(Date:6/24/2016)... discussions on a range of subjects including policies, debt and ... Poloz. Speaking at a lecture to the Canadian ... to the country,s inflation target, which is set by both ... "In certain areas there needs to be ... why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology:
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
(Date:3/18/2016)... LONDON , March 18, 2016 ... Established Suppliers of Biometrics, ICT, Manned & Unmanned Vehicles, Physical ... & security companies in the border security market and ... and Europe has led ... your companies improved success. --> defence & ...
Breaking Biology News(10 mins):